TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T57278	Ephrin type-A receptor 2	B1JGT6	(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-(2-oxopropyl)pentanamide	Investigative	71720468	C27H45NO3	431.7	C[C@H](CCC(=O)NCC(=O)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C	IC50 > 316227.77 nM	Non binder
T57278	Ephrin type-A receptor 2	B7FB5Y	(2R)-2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]butanedioic acid	Investigative	71604873	C28H45NO6	491.7	C[C@H](CCC(=O)N[C@H](CC(=O)O)C(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C	IC50 > 316227.77 nM	Non binder
T57278	Ephrin type-A receptor 2	BB49UM	(2R)-4-Amino-2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-4-oxobutanoic acid	Investigative	71604724	C28H46N2O5	490.7	C[C@H](CCC(=O)N[C@H](CC(=O)N)C(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C	IC50 > 316227.77 nM	Non binder
T57278	Ephrin type-A receptor 2	BW73YD	N-(24-Oxo-3alpha-hydroxy-5beta-cholane-24-yl)aspartic acid	Investigative	11698847	C28H45NO6	491.7	C[C@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C	IC50 > 316227.77 nM	Non binder
T57278	Ephrin type-A receptor 2	BZ24FD	(2S)-4-Amino-2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-4-oxobutanoic acid	Investigative	71604723	C28H46N2O5	490.7	C[C@H](CCC(=O)N[C@@H](CC(=O)N)C(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C	IC50 > 316227.77 nM	Non binder